• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. X-ALT; FMP NEUTRAL LINER, 32MM, MP7, HXE-PLUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. X-ALT; FMP NEUTRAL LINER, 32MM, MP7, HXE-PLUS Back to Search Results
Model Number 431-32-707
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 07/03/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The reason for this revision surgery was an infection.The previous surgery and the surgery detailed in this investigation occurred 28 days apart.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the possible infection or inhibited the patient's immune system.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The device was disposed of at the hospital and not made available to djo surgical for examination.A review of the implant device history records (dhr), shows that the reported component used in the previous surgery, when released for use, met design and manufacturing requirements.There were no non-conforming material reports associated with the product that may have contributed to the reported event.The device was verified to have gone through an acceptable sterilization process and was within its expiration date at the time of the previous surgery.Customer complaint history of the reported device showed no present trends or on-going issues that are in need of review.The root cause of this complaint was reported as an infection.There were no findings during this investigation that indicate that the reported device was the source or had a direct connection with the patient's infection.Due to the short time between the original surgery and the revision, it is possible that the infection was acquired in the hospital (nosocomial).It is also possible that the patient was not compliant with post surgical instructions.There are multiple factors that may contribute to an infection that are outside of the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.
 
Event or Problem Description
Revision surgery - due to possible infection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
X-ALT
Common Device Name
FMP NEUTRAL LINER, 32MM, MP7, HXE-PLUS
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin TX 78758 5445
MDR Report Key8855307
Report Number1644408-2019-00716
Device Sequence Number2654516
Product Code OQG
UDI-Device Identifier00888912084635
UDI-Public(01)00888912084635
Combination Product (Y/N)N
Initial Reporter StateLA
Initial Reporter CountryUS
PMA/510(K) Number
K140130
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Device Explanted Year2019
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 08/02/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/21/2024
Device Model Number431-32-707
Device Catalogue Number431-32-707
Device Lot Number649N1044
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/03/2019
Initial Report FDA Received Date08/02/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
400-03-322 LOT 861B1150
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
-
-